InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-41.9%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by GILLIS EDWARD M, Chairman & CEO. Officer active across 1 company, notably BioCardia, Inc.. In total, 10 reports have been logged. Split: 0 buy · 1 sell. Total volume traded: €6k. Activity tracked since 10 June 2021. The latest transaction was filed on 2 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations10 total
17,269 shares@ US$1.24Common StockSEC:0001437749-26-022967:0
39,521 sharesCommon StockSEC:0001437749-26-022363:0
3,257 shares@ US$2.002.8% of flowCommon StockSEC:0001437749-24-038363:0
15,808 shares@ US$2.6517.3% of flowCommon StockSEC:0001437749-24-031413:0
15,512 shares@ US$1.7711.6% of flowCommon StockSEC:0001437749-23-016523:0
40,490 shares@ US$1.7028.9% of flowCommon StockSEC:0001437749-23-015518:0
12,358 shares@ US$1.320.14% mcap18.1% of flowCommon StockSEC:0001437749-22-012953:0
30,155 shares0Common StockSEC:0001437749-22-009164:0
9,953 shares@ US$4.350.32% mcap41.0% of flowCommon StockSEC:0001437749-21-014632:0
9,953 shares@ US$4.3516.1% of flowCommon StockSEC:0001437749-21-014632
10 of 10 declarations
About GILLIS EDWARD M
Edward M. Gillis is the Senior Vice President, Devices at BioCardia, Inc. He oversees the operations related to the company's medical devices, playing a key role in the development of innovative products. His expertise is essential for BioCardia's growth.
